TVGNW logo

Tevogen Bio Holdings (TVGNW) Stock

Profile

Full Name:

Tevogen Bio Holdings Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

Indexes:

Not included

Website:

http://tevogen.com

Description:

Tevogen Bio is a biotechnology company focused on developing innovative therapies for cancer and infectious diseases using its proprietary T-cell technology.

Key Details

Price

$0.08

Market Cap

-

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$0.00(0.00% YoY)

Annual EPS

-

PE Ratio

-

Annual ROE

9.68%

Annual Debt To Equity

-2.35

Beta

-2.05

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

N/A

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

No data about analysts updates

Screeners with TVGNW included

No data

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.08
TVGNW price is $0.08

Price YTD Change

+55.37%
TVGNW price is up +55.37% since January 1st

Price All-time High

$0.11
TVGNW price is currently -23.80% below its historical high of $0.11

Beta

-2.05
TVGNW beta is -2.05

200-day SMA

$0.05
TVGNW price is currently +86.03% above its 200-day simple moving average

14-day RSI

58.06
TVGNW 14-day relative strength index is 58.06

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Revenue 3-Year Change

+0%
TVGNW annual revenue is up +0% over the past 3 years

Annual Net Income 3-Year Change

+99.57%
TVGNW annual net profit is up +99.57% over the past 3 years

Annual Operating Profit

-$2.27 M
TVGNW annual operaing income is -$2.27 million

Annual Operating Profit 3-Year Change

+50.76%
TVGNW annual operaing income is up +50.76% over the past 3 years

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual ROE

9.68%
TVGNW annual return on equity is 9.68%

Annual ROA

-0.40%
TVGNW annual return on assets is -0.40%

Annual EBIT

$188.71 K
TVGNW annual earnings before interest & taxes is $188.71 thousand

Annual EBITDA

-$2.27 M
TVGNW annual earnings before interest, taxes, depreciation & amortization is -$2.27 million

Annual Interest Coverage Ratio

0.74
TVGNW annual interest coverage ratio is 0.74

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Current Ratio

0.12
TVGNW annual current ratio is 0.12

Annual Total Assets

$17.04 M
TVGNW annual total assets is $17.04 million

Annual Current Assets

$355.84 K
TVGNW annual total current assets is $355.84 thousand

Annual Total Liabilities

$17.73 M
TVGNW annual total liabilities is $17.73 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual CFO 3-Year Change

+73.91%
TVGNW annual cash flow from operations is up +73.91% over the past 3 years

Annual CFI 3-Year Change

+312618.28%
TVGNW annual cash flow from investing activities is up +312618.28% over the past 3 years

Annual CFF 3-Year Change

-2833.29%
TVGNW annual cash flow from financing activities is down -2833.29% over the past 3 years

Annual FCF

-$1.38 M
TVGNW annual free cash flow is -$1.38 million

Annual FCF 3-Year Change

+74.44%
TVGNW annual free cash flow is up +74.44% over the past 3 years

Institutional Ownership

Similar stocks

FAQ

  • What is the primary business of Tevogen Bio Holdings?
  • What is the ticker symbol for Tevogen Bio Holdings?
  • Does Tevogen Bio Holdings pay dividends?
  • What sector is Tevogen Bio Holdings in?
  • What industry is Tevogen Bio Holdings in?
  • What country is Tevogen Bio Holdings based in?
  • Is Tevogen Bio Holdings in the S&P 500?
  • Is Tevogen Bio Holdings in the NASDAQ 100?
  • Is Tevogen Bio Holdings in the Dow Jones?
  • When does Tevogen Bio Holdings report earnings?

What is the primary business of Tevogen Bio Holdings?

Tevogen Bio is a biotechnology company focused on developing innovative therapies for cancer and infectious diseases using its proprietary T-cell technology.

What is the ticker symbol for Tevogen Bio Holdings?

The ticker symbol for Tevogen Bio Holdings is NASDAQ:TVGNW

Does Tevogen Bio Holdings pay dividends?

No, Tevogen Bio Holdings does not pay dividends

What sector is Tevogen Bio Holdings in?

Tevogen Bio Holdings is in the Healthcare sector

What industry is Tevogen Bio Holdings in?

Tevogen Bio Holdings is in the Biotechnology industry

What country is Tevogen Bio Holdings based in?

Tevogen Bio Holdings is headquartered in United States

Is Tevogen Bio Holdings in the S&P 500?

No, Tevogen Bio Holdings is not included in the S&P 500 index

Is Tevogen Bio Holdings in the NASDAQ 100?

No, Tevogen Bio Holdings is not included in the NASDAQ 100 index

Is Tevogen Bio Holdings in the Dow Jones?

No, Tevogen Bio Holdings is not included in the Dow Jones index

When does Tevogen Bio Holdings report earnings?

The date for Tevogen Bio Holdings's next earnings report has not been announced yet